Design Therapeutics, Inc. Income Statement

Income Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & Cost
Revenue 0.23M11.33M12.79M
Interest income
Interest Income - Total 11.33M12.79M
Interest expenses
Interest Income - Net 11.33M12.79M
Operating Items
Research & Development 6.06M
Wages, Salaries and Other 0.41M
Selling, General & Administrative 2.50M
Operating Expenses 8.56M
Operating Income -8.33M
EBIT -8.33M
Non-operating items
Other Non Operating Income 0.05M
Non Operating Income 0.05M
Net income details
EBT -8.33M
Profit After Tax -8.28M
Income from Continuing Operations -8.33M
Consolidated Net Income -8.33M
Income towards Parent Company -8.33M
Net Income towards Common Stockholders -8.33M
Additional items
EPS (Basic) -0.00M
Shares Outstanding (Weighted Average) 53.82M55.66M55.91M56.00M56.62M
EBITDA -8.33M